Ming Huang
- Cancer Research top 5%
- Internal Medicine top 5%
- Infectious Diseases top 5%
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 5
- Molecular Biology top 10%
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
-
- Bladder and Urothelial Cancer Treatments 7
- Urinary and Genital Oncology Studies 5
-
- COVID-19 and Mental Health 4
-
- Long-Term Effects of COVID-19 4
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (4 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Ming Huang
66 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 450
- Internal Medicine 79
- Infectious Diseases 314
- Oncology 385
- Molecular Biology 908
Countries citing papers authored by Ming Huang
This map shows the geographic impact of Ming Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Huang more than expected).
Fields of papers citing papers by Ming Huang
This network shows the impact of papers produced by Ming Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Huang. The network helps show where Ming Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 12 | |
| 7 | 2023 | 24 | |
| 8 | NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancerbreakdown → | 2023 | 128 |
| 9 | 2023 | 14 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 76 | |
| 12 | 2022 | 3 | |
| 13 | 2021 | 22 | |
| 14 | 2021 | 4 | |
| 15 | 2020 | 61 | |
| 16 | Targeted nanoparticle-mediated LHPP for melanoma treatment | 2019 | 3 |
| 17 | 2019 | 3 | |
| 18 | 2018 | 180 | |
| 19 | 2016 | 49 | |
| 20 | 2015 | 12 |
About Ming Huang
Ming Huang is a scholar working on Hepatology, Cancer Research and Pathology and Forensic Medicine, having authored 73 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Bladder and Urothelial Cancer Treatments (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Urinary and Genital Oncology Studies (5 papers), Epigenetics and DNA Methylation (5 papers), COVID-19 and Mental Health (4 papers) and Long-Term Effects of COVID-19 (4 papers). The work is most often cited by research in Cancer Research (450 citations), Internal Medicine (79 citations) and Infectious Diseases (314 citations). Ming Huang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Tianxin Lin, Shiyu Yin, Ning Tang, Dengju Li, Xu Chen, Ruihui Xie, Jian Huang, Ziyue Chen, Qianghua Zhou and Jinli Han. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.